Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect
- PMID: 11140268
- DOI: 10.1562/0031-8655(2000)072<0794:TAAPTO>2.0.CO;2
Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect
Abstract
Light fractionation with dark periods of the order of hours has been shown to considerably increase the efficacy of 5-aminolevulinic acid-photodynamic therapy (ALA-PDT). Recent investigations have suggested that this increase may be due to the resynthesis of protoporphyrin IX (PpIX) during the dark period following the first illumination that is then utilized in the second light fraction. We have investigated the kinetics of PpIX fluorescence and PDT-induced damage during PDT in the normal skin of the SKH1 HR hairless mouse. A single illumination (514 nm), with light fluences of 5, 10 and 50 J cm-2 was performed 4 h after the application of 20% ALA, to determine the effect of PDT on the synthesis of PpIX. Results show that the kinetics of PpIX fluorescence after illumination are dependent on the fluence delivered; the resynthesis of PpIX is progressively inhibited following fluences above 10 J cm-2. In order to determine the influence of the PpIX fluorescence intensity at the time of the second illumination on the visual skin damage, 5 + 95 and 50 + 50 J cm-2 (when significantly less PpIX fluorescence is present before the second illumination), were delivered with a dark interval of 2 h between light fractions. Each scheme was compared to illumination with 100 J cm-2 in a single fraction delivered 4 or 6 h after the application of ALA. As we have shown previously greater skin damage results when an equal light fluence is delivered in two fractions. However, significantly more damage results when 5 J cm-2 is delivered in the first light fraction. Also, delivering 5 J cm-2 at 5 mW cm-2 + 95 J cm-2 at 50 mW cm-2 results in a reduction in visual skin damage from that obtained with 5 + 95 J cm-2 at 50 mW cm-2. A similar reduction in damage is observed if 5 + 45 J cm-2 are delivered at 50 mW cm-2. PpIX photoproducts are formed during illumination and subsequently photobleached. PpIX photoproducts do not dissipate in the 2 h dark interval between illuminations.
Similar articles
-
Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.Photochem Photobiol. 2003 Mar;77(3):319-23. doi: 10.1562/0031-8655(2003)077<0319:DATOTF>2.0.CO;2. Photochem Photobiol. 2003. PMID: 12685661
-
The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.Photodiagnosis Photodyn Ther. 2013 Dec;10(4):703-9. doi: 10.1016/j.pdpdt.2013.09.002. Epub 2013 Oct 15. Photodiagnosis Photodyn Ther. 2013. PMID: 24284130
-
Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.Photochem Photobiol. 1999 Dec;70(6):921-9. Photochem Photobiol. 1999. PMID: 10628304
-
Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.Photodiagnosis Photodyn Ther. 2016 Sep;15:236-44. doi: 10.1016/j.pdpdt.2016.05.008. Epub 2016 Jun 7. Photodiagnosis Photodyn Ther. 2016. PMID: 27288253 Review.
-
Topical aminolevulinic acid HCl photodynamic therapy.Am J Clin Dermatol. 2000 Mar-Apr;1(2):133-9; discussion 140-1. doi: 10.2165/00128071-200001020-00009. Am J Clin Dermatol. 2000. PMID: 11702313 Review.
Cited by
-
Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.Br J Cancer. 2003 May 6;88(9):1462-9. doi: 10.1038/sj.bjc.6600910. Br J Cancer. 2003. PMID: 12778078 Free PMC article.
-
Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.Br J Cancer. 2016 Sep 27;115(7):805-13. doi: 10.1038/bjc.2016.267. Epub 2016 Aug 30. Br J Cancer. 2016. PMID: 27575852 Free PMC article.
-
Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.Dermatology. 2022;238(6):1044-1049. doi: 10.1159/000524745. Epub 2022 May 20. Dermatology. 2022. PMID: 35598594 Free PMC article. Clinical Trial.
-
Daylight-PDT: everything under the sun.Biochem Soc Trans. 2022 Apr 29;50(2):975-985. doi: 10.1042/BST20200822. Biochem Soc Trans. 2022. PMID: 35385082 Free PMC article. Review.
-
Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.Pharm Res. 2006 Feb;23(2):360-6. doi: 10.1007/s11095-005-9261-x. Epub 2006 Jan 1. Pharm Res. 2006. PMID: 16341572
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials